RVXot and nbb it seems that the cancer area is almost infinitely complex because there seems to be thousands of cancers and hundreds if not thousands of trials in progress. The mCRPC results and chemical strategy seem sound scientificly (yet to be analysed and proven). Eastern seemed to not step up to further financing on the BOM CVOT. Is this a decision on science or an investment decision because ZCC has the RPS of apabetalone. Either way it seems like a vote of confidence in RVX and Zenith science IMHO.

GLTA

Toinv